Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIME: IVIG Therapy Following Portoenterostomy in Infants With Biliary Atresia
NCT01854827Phase 2Completed
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Oct 2013
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of intravenous immunoglobulin G in biliary atresia, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Oct 2013; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
biliary atresia
Beyond the preview
Go deeper on NCT01854827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01854827.